Mandate Vinge advises Cellink in conjunction with the acquisition of cytena

August 05, 2019

Vinge has advised Cellink AB (publ) in connection with the acquisition of all shares in cytena GmbH. cytena is a life science company which focuses on single cell technologies.

Cytena was established in 2014 from the Institute for Microsystems Technology at the University of Freiburg and primarily sells solutions for the handling of biological cells. The purchase price amounts to MEUR 30.25, corresponding to MSEK 323, and is paid with 1/3 in cash and 2/3 in newly issued Cellink shares. Cellink will convene an extraordinary general meeting which will resolve upon the directed issue of shares to the sellers of cytena.

Vinge’s team primarily consisted of Anders Strid, Daniel Lennartsson Anderås, Alexander Lindeberg and Adam Loewenstein.

M&A in Sweden and the impact of COVID-19

We started to see signs of a decrease in M&A activity during Q4 2019 and following a relatively sluggish start to 2020, COVID-19 has had a significant impact on M&A activity in Sweden. In this note we address some of the key observations.
April 07, 2020

Update regarding the implications of Covid-19 for upcoming AGMs

The outbreak of the coronavirus disease has had a significant impact on people and businesses. The situation has also raised questions about the possibility of physical attendance at upcoming AGMs. Due to new temporary legislation and new instructions regarding the interpretation of the Swedish Corporate Governance Code, as well as the authorities’ updated recommendations, Vinge publishes this update regarding companies' alternatives for the upcoming AGMs.
April 03, 2020

Brexit and data protection

The transfer of personal data is of key importance to many businesses. It is an area that is affected by Brexit and companies must consider how to deal with the changes brought upon by the British departure. This note discusses the implications of Brexit for the transfer of personal data and offers guidance to companies and other parties.
April 01, 2020